It was one of the first CAR-T treatments (genetic modification) that was acquired in Spain. Its price per unit is around 327,000 euros.

It is a gene therapy product used to treat adults and children with vision loss due to hereditary retinal dystrophy. The dose costs 20,000 euros. The treatment